Golmehr Sistani

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Neuroendocrine Tumors

Mild Cognitive Impairment

Placebo Controlled

Top Venues

Current oncology (Toronto, Ont.)

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Mina M Swiha, Duncan E K Sutherland, Golmehr Sistani, Alireza Khatami, Rami M Abazid, Amol Mujoomdar, Daniele P Wiseman, Jonathan G Romsa, Robert H Reid, David T Laidley
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS). Journal of cancer research and clinical oncology (2021)
Golmehr Sistani, Yasmine T Sallam, Wai P Ng, Andrew E Leung, Lee Cyn Ang, Manas Sharma
Spinal Intradural Phosphaturic Mesenchymal Tumor. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2021)
Golmehr Sistani, Duncan E K Sutherland, Amol Mujoomdar, Daniele P Wiseman, Alireza Khatami, Elena Tsvetkova, Robert H Reid, David T Laidley
Efficacy of 177Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study. Current oncology (Toronto, Ont.) 28 (1) (2020)